Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 675

1.

Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.

Leary SE, Griffin KF, Garmory HS, Williamson ED, Titball RW.

Microb Pathog. 1997 Sep;23(3):167-79.

PMID:
9281474
4.

Expression of Yersinia pestis V antigen in attenuated salmonella typhimurium: development of a novel vaccine for plague.

Leary SE, Eley SM, Williamson ED, Titball RW.

Contrib Microbiol Immunol. 1995;13:216-7. No abstract available.

PMID:
8833838
5.
6.

Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270.

Qi Z, Zhou L, Zhang Q, Ren L, Dai R, Wu B, Wang T, Zhu Z, Yang Y, Cui B, Wang Z, Wang H, Qiu Y, Guo Z, Yang R, Wang X.

Vaccine. 2010 Feb 10;28(6):1655-60. doi: 10.1016/j.vaccine.2009.02.078. Epub 2009 Mar 9.

PMID:
20079562
7.

Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague.

Leary SE, Williamson ED, Griffin KF, Russell P, Eley SM, Titball RW.

Infect Immun. 1995 Aug;63(8):2854-8.

8.

A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague.

Wang S, Heilman D, Liu F, Giehl T, Joshi S, Huang X, Chou TH, Goguen J, Lu S.

Vaccine. 2004 Sep 3;22(25-26):3348-57.

PMID:
15308359
9.

Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.

Sabhnani L, Manocha M, Sridevi K, Shashikiran D, Rayanade R, Rao DN.

FEMS Immunol Med Microbiol. 2003 Oct 15;38(3):215-29.

10.

Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague.

Yang X, Hinnebusch BJ, Trunkle T, Bosio CM, Suo Z, Tighe M, Harmsen A, Becker T, Crist K, Walters N, Avci R, Pascual DW.

J Immunol. 2007 Jan 15;178(2):1059-67.

11.

Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization.

Hill J, Leary SE, Griffin KF, Williamson ED, Titball RW.

Infect Immun. 1997 Nov;65(11):4476-82.

12.

A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague.

Chichester JA, Musiychuk K, Farrance CE, Mett V, Lyons J, Mett V, Yusibov V.

Vaccine. 2009 May 26;27(25-26):3471-4. doi: 10.1016/j.vaccine.2009.01.050. Epub 2009 Feb 5.

PMID:
19200825
13.

Purification and characterization of a recombinant Yersinia pestis V-F1 "Reversed" fusion protein for use as a new subunit vaccine against plague.

Goodin JL, Powell BS, Enama JT, Raab RW, McKown RL, Coffman GL, Andrews GP.

Protein Expr Purif. 2011 Mar;76(1):136-44. doi: 10.1016/j.pep.2010.10.011. Epub 2010 Nov 3.

PMID:
21055471
14.

Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague.

Williamson ED, Stagg AJ, Eley SM, Taylor R, Green M, Jones SM, Titball RW.

Vaccine. 2007 Jan 22;25(6):1142-8. Epub 2006 Oct 2.

PMID:
17101198
15.

Construction and screening of attenuated ΔphoP/Q Salmonella typhimurium vectored plague vaccine candidates.

Sizemore DR, Warner EA, Lawrence JA, Thomas LJ, Roland KL, Killeen KP.

Hum Vaccin Immunother. 2012 Mar;8(3):371-83. doi: 10.4161/hv.18670. Epub 2012 Feb 13.

PMID:
22327496
16.

Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice.

Little SF, Webster WM, Wilhelm H, Fisher D, Norris SL, Powell BS, Enama J, Adamovicz JJ.

Vaccine. 2010 Jan 22;28(4):934-9. doi: 10.1016/j.vaccine.2009.10.143. Epub 2009 Nov 17.

PMID:
19925906
17.
18.

A new improved sub-unit vaccine for plague: the basis of protection.

Williamson ED, Eley SM, Griffin KF, Green M, Russell P, Leary SE, Oyston PC, Easterbrook T, Reddin KM, Robinson A, et al.

FEMS Immunol Med Microbiol. 1995 Dec;12(3-4):223-30.

PMID:
8745007
19.

Recombinant raccoon pox vaccine protects mice against lethal plague.

Osorio JE, Powell TD, Frank RS, Moss K, Haanes EJ, Smith SR, Rocke TE, Stinchcomb DT.

Vaccine. 2003 Mar 7;21(11-12):1232-8.

PMID:
12559803
20.

Cell-mediated immune response and Th/Th cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis.

Gupta G, Khan AA, Rao DN.

Scand J Immunol. 2010 Mar;71(3):186-98. doi: 10.1111/j.1365-3083.2009.02365.x.

Supplemental Content

Support Center